Skip to content

Effect of dorsal root ganglion pulse radiofrequency combined with sympathetic nerve radiofrequency ablation on recovery of limb nerve function after stroke

Effect of dorsal root ganglion pulse radiofrequency combined with sympathetic nerve radiofrequency ablation on recovery of limb nerve function after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088019
Enrollment
Unknown
Registered
2024-08-09
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb nerve function injury after stroke

Interventions

C:Dorsal root ganglion pulse radiofrequency
S:Sympathetic nerve radiofrequency ablation
H:Dorsal root ganglion pulse radiofrequency combined with sympathetic nerve radiofrequency ablation

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with hemorrhagic or ischemic stroke whose course of disease is more than 1 month and whose condition is stable; 18 years = age =90 years; The VAS scores of pain, numbness and cold of the affected limb were =4 points; 5 points = Neurological Impairment score (NIHSS) =20 points.

Exclusion criteria

Exclusion criteria: patients who could not communicate normally; Have a history of limb disease or surgery; Patients with infection or tumor at the puncture site; Pregnant or lactating women, patients with serious cardiovascular diseases, liver and kidney dysfunction, abnormal coagulation function, etc.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Pittsburgh sleep quality index, PSQI;Oral dosage of pain medications such as barapentin capsules;Fugl-Meyer Assessment Scale, FMAS;Current perception threshold;

Countries

China

Contacts

Public ContactFei Yong

The First Hospital of Jiaxing

jxfy6666662022@163.com+86 155 2511 2590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026